Posted on August 21, 20258/21/25
Redefining CAR-T Access: Strategic Implications of the FDA’s REMS Decision
Posted on July 21, 20257/21/25
Empowering Scientific Dialogue: Key Takeaways from the FDA’s SIUU Guidance
Posted on May 29, 20255/29/25
Navigating the Final FDA SIUU Guidance: Strategic Considerations for Scientific Exchange at ASCO and Other Congresses
Posted on April 3, 20254/3/25
Beyond Clinical Trials: Real-World Evidence Illuminates the Value of First-Line CDK4/6i in Metastatic Breast Cancer
Posted on March 12, 20253/12/25
Making Cutting-Edge Cancer Treatments Accessible: Advancing CAR-T Therapy to the Community Practice
Posted on December 10, 202412/10/24
Association Between Targeted Therapy and Survival in Patients with Myelodysplastic Syndromes
Posted on December 9, 202412/9/24
Association Between Targeted Therapy and Survival in Patients With Acute Myeloid Leukemia
Posted on November 26, 202411/26/24
The Importance of Quality-of-Life Metrics in mCRPC
Posted on November 6, 202411/6/24